We propose that -26 G>A polymorphism in the 5' UTR of BRCA2 has a regulatory role and acts as one of the risk factors, modulating the function of BRCA2 in breast cancer pathogenesis, further influenced by codon 72 polymorphism in the p53 gene. This evidence concerns the gene BRCA2 and breast carcinoma.